128 related articles for article (PubMed ID: 37449465)
1. Posttreatment positivity of BCR::ABL1 in acute lymphoblastic leukemia: Should we keep track?
Zuna J; Hovorkova L; Krotka J; Winkowska L; Novak Z; Sramkova L; Stary J; Trka J; Cazzaniga G; Cario G; Zaliova M
Am J Hematol; 2023 Oct; 98(10):E269-E271. PubMed ID: 37449465
[No Abstract] [Full Text] [Related]
2. BCR-ABL1 positive lymphoblastic lymphoma - should it be treated like a B-lymphoblastic leukemia with
Takahashi T; Ichikawa S; Ichinohasama R; Harigae H
Leuk Lymphoma; 2020 May; 61(5):1265-1267. PubMed ID: 31876209
[No Abstract] [Full Text] [Related]
3. BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia.
Rizzotto L; Saccenti E; Sofritti O; Daghia G; Volta E; Caprini E; Lupini L; Tammiso E; Bardi A; Lista E; Ciccone M; Russo G; Negrini M; Cuneo A; Rigolin GM
Leuk Lymphoma; 2013 Sep; 54(9):2065-7. PubMed ID: 23323950
[No Abstract] [Full Text] [Related]
4. A novel e8a2 BCR-ABL1 fusion with insertion of RALGPS1 exon 8 in a patient with relapsed Philadelphia chromosome-positive acute lymphoblastic leukemia.
McCarron SL; Kelly J; Coen N; McCabe S; Fay M; O'Dwyer M; Hayden PJ; Langabeer SE
Leuk Lymphoma; 2011 May; 52(5):919-21. PubMed ID: 21338279
[No Abstract] [Full Text] [Related]
5. BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy.
Cario G; Leoni V; Conter V; Baruchel A; Schrappe M; Biondi A
Haematologica; 2020 Sep; 105(9):2200-2204. PubMed ID: 33054045
[No Abstract] [Full Text] [Related]
6. Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.
Cazzaniga G; De Lorenzo P; Alten J; Röttgers S; Hancock J; Saha V; Castor A; Madsen HO; Gandemer V; Cavé H; Leoni V; Köhler R; Ferrari GM; Bleckmann K; Pieters R; van der Velden V; Stary J; Zuna J; Escherich G; Stadt UZ; Aricò M; Conter V; Schrappe M; Valsecchi MG; Biondi A
Haematologica; 2018 Jan; 103(1):107-115. PubMed ID: 29079599
[TBL] [Abstract][Full Text] [Related]
7. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
Andolina JR
Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
[No Abstract] [Full Text] [Related]
8. MicroRNA signature in BCR-ABL1-like and BCR-ABL1-positive childhood acute lymphoblastic leukemia: similarities and dissimilarities.
Akbari Moqadam F; Lange-Turenhout EA; van der Veer A; Marchante JR; Boer JM; Pieters R; den Boer M
Leuk Lymphoma; 2014 Aug; 55(8):1942-5. PubMed ID: 24164534
[No Abstract] [Full Text] [Related]
9. Two cases of acute lymphoblastic leukemia with an e1a3 BCR-ABL1 fusion transcript.
Shin SY; Cho JH; Kim HJ; Jang JH; Lee ST; Kim SH
Ann Lab Med; 2015 Jan; 35(1):159-61. PubMed ID: 25553301
[No Abstract] [Full Text] [Related]
10. Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.
Oya S; Morishige S; Ozawa H; Sasaki K; Semba Y; Yamasaki Y; Nakamura T; Aoyama K; Seki R; Mouri F; Osaki K; Miyamoto T; Maeda T; Nagafuji K
Int J Hematol; 2021 Feb; 113(2):285-289. PubMed ID: 32951102
[TBL] [Abstract][Full Text] [Related]
11. BCR/ABL1-Like Acute Lymphoblastic Leukemia: From Diagnostic Approaches to Molecularly Targeted Therapy.
Płotka A; Lewandowski K
Acta Haematol; 2022; 145(2):122-131. PubMed ID: 34818644
[TBL] [Abstract][Full Text] [Related]
12. ABL1 gene deletion without BCR/ABL1 rearrangement in a young adolescent with precursor B-cell acute lymphoblastic leukemia: clinical study and literature review.
Kim MJ; Yoon HS; Lim G; Kim SY; Lee HJ; Suh JT; Lee J; Lee WI; Park TS
Cancer Genet Cytogenet; 2010 Jan; 196(2):184-8. PubMed ID: 20082857
[TBL] [Abstract][Full Text] [Related]
13. Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.
Kurita D; Hatta Y; Hojo A; Kura Y; Sawada U; Kanda Y; Takei M
Cancer Genet; 2016 Apr; 209(4):161-5. PubMed ID: 26854094
[TBL] [Abstract][Full Text] [Related]
14. BCR/ABL1-like acute lymphoblastic leukemia: How to diagnose and treat?
Chiaretti S; Messina M; Foà R
Cancer; 2019 Jan; 125(2):194-204. PubMed ID: 30561755
[TBL] [Abstract][Full Text] [Related]
15. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report.
De Benedittis C; Papayannidis C; Venturi C; Abbenante MC; Paolini S; Parisi S; Sartor C; Cavo M; Martinelli G; Soverini S
BMC Cancer; 2017 Aug; 17(1):523. PubMed ID: 28779753
[TBL] [Abstract][Full Text] [Related]
16. [Mutations in the BCR-ABL1 gene in a peruvian patient with acute lymphoblastic leukemia resistant to therapy].
Ortiz CA; Alvarez YP; Dongo-Pflucker KL; Valdivia E; Mendoza Fernández J; Dávila S; Mora-Alférez P
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(2):162-166. PubMed ID: 28657534
[TBL] [Abstract][Full Text] [Related]
17. The e1a3 BCR-ABL1 fusion transcript in philadelphia chromosome-positive acute lymphoblastic leukemia.
Langabeer SE
Ann Lab Med; 2015 Sep; 35(5):540-1. PubMed ID: 26206693
[No Abstract] [Full Text] [Related]
18. Outcomes of children with BCR-ABL1–like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease.
Roberts KG; Pei D; Campana D; Payne-Turner D; Li Y; Cheng C; Sandlund JT; Jeha S; Easton J; Becksfort J; Zhang J; Coustan-Smith E; Raimondi SC; Leung WH; Relling MV; Evans WE; Downing JR; Mullighan CG; Pui CH
J Clin Oncol; 2014 Sep; 32(27):3012-20. PubMed ID: 25049327
[TBL] [Abstract][Full Text] [Related]
19. BCR-ABL1-positive acute myeloid leukaemia relapsing as acute lymphoblastic leukaemia.
Chen X; Chen H
Br J Haematol; 2020 May; 189(4):591. PubMed ID: 31943141
[No Abstract] [Full Text] [Related]
20. Are we ABL to do better for children with BCR-ABL1-like acute lymphocytic leukaemia?
Tasian SK
Lancet Haematol; 2021 Jan; 8(1):e6-e8. PubMed ID: 33357484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
